Epidemiological, Clinical and Therapeutic Aspects of Schizoaffective Disorder at the CHU-Campus of Lomé (Togo)
- 1 Clinique Universitaire de Psychiatrie et de Psychologie Médicale, CHU Sylvanus Olympio-Lomé, Hôpital Psychiatrique de Zébé-Aného, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo
- 2 Service de Psychiatrie, Faculté des Sciences de la Santé, Université de Kara, Kara, Togo
- 3 Clinique de Psychiatrie et de Psychologie Médicale, Faculté des Sciences de la Santé, CHU Campus, Université de Lomé, Lomé, Togo
- 4 Clinique Médico-Psychiatrique de Lomé, Lomé, Togo
- 5 Clinique Universitaire de Psychiatrie et de Psychologie Médicale, CHU Sylvanus Olympio-Lomé, Hôpital Psychiatrique de Zébé-Aného, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo
- 6 Clinique de Psychiatrie et de Psychologie Médicale, Faculté des Sciences de la Santé, CHU Campus, Université de Lomé, Lomé, Togo
Abstract
Introduction: Schizoaffective disorder is a chronic psychotic disorder. It is characterized by the simultaneous presence of symptoms of a characterized mood disorder and symptoms of schizophrenia. Data on this disorder are almost non-existent in West Africa. The objective was to describe the epidemiological, clinical and therapeutic aspects of schizoaffective disorder at the Campus University Hospital Centre (CHU-Campus) of Lomé in Togo. Framework and Method: This was a retrospective study with a descriptive aim on patients hospitalized at the Clinic of Psychiatry and Medical Psychology (CPPM) of CHU-Campus from January 1st, 2013 to December 31, 2018. Results: A total of 46 patients were included in this study. Their mean age was 39.5 years with extremes ranging from 14 to 65 years. Females had predominated at 52.18% or a sex ratio of 0.91. Married people represented 47.83%. Primary education represented 34.80%. The unemployed were in the majority at 32.92%. Sixty-five point twenty two percent (65.22%) of the patients had a personal psychiatric history. All patients had presented with delusions plus other psychotic and mood symptoms. Almost all patients (97.82%) had received a thymoregulator associated with a first generation antipsychotic (95.65%). Conclusion: More studies should be done in our countries to describe the cultural aspects of this disease.
- Miller, J.N. and Black, D.W. (2019) Schizoaffective Disorder: A Review. Annals of Clinical Psychiatry, 31, 47-53.
- Malhi, G.S., Green, M., Fagiolini, A., Peselow, E.D. and Kumari, V. (2008) Schizoaffective Disorder: Diagnostic Issues and Future Recommendations. Bipolar Disorder, 10, 215-230. https://doi.org/10.1111/j.1399-5618.2007.00564.x
- Besche-Richard, C. Dépression, schizophrénie et troubles schizo-affectifs. https://studylibfr.com/doc/2205324/dépression--schizophrénie-et-troubles-schizo-affectifs
- Perala, J., Suvisaari, J., Saarni, S.I., et al. (2007) Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population. Archives of General Psychiatry, 64, 19-28. https://doi.org/10.1001/archpsyc.64.1.19
- Koundoul, A., Seck, D., Wone, I., Kane, Y., Seck, S. and Thiam, M.H. (2021) Profil des Patients Porteurs d’Affections Psychiatriques au centre Psychiatrique de Ziguinchor au sud du Sénégal. Health Sciences and Diseases, 22, 68-72.
- Salifou, S., Wenkourama, D., Soedje, K.M.A., et al. (2018) Profil des patients vus en consultation psychiatrique au CHU Campus de Lomé. Health Sciences and Diseases, 19, 48-52.
- Salifou, S., Anagonou, L., Wenkourama, D., et al. (2017) Alliance et observance thérapeutique chez les patients sous antipsychotique au CNHU HKM de cotonou. Psy Cause, 75, 43-46.
- Eyoum, C., Mbongo’o, G.C., Njiengwe, E., et al. (2021) Pratique de la Psychiatrie à l’Hopital Laquintinie de Douala: Evaluation de Trois Ans d’Activités. Health Sciences and Diseases, 22, 76-81.
- Mancuso, S.G., Morgan, V.A., Mitchell, P.B., Berk, M., Young, A. and Castle, D.J. (2015) A Comparison of Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder: Results from the Second Australian National Psychosis Survey. Journal of Affective Disorders, 172, 30-37. https://doi.org/10.1016/j.jad.2014.09.035
- Olfson, M., Marcus, S.C. and Wan, G.J. (2009) Treatment Patterns for Schizoaffective Disorder and Schizophrenia among Medicaid Patients. Psychiatric Services, 60, 210-216. https://doi.org/10.1176/ps.2009.60.2.210
- Tognidé, C.M., Klikpo, E., Gansou, G.M., et al. (2010) Itinéraire thérapeutique des malades mentaux recus dans le service de psychiatrie du CNHU-HKM de Cotonou (Bénin). Le Bénin Médical, 45/46, 32-38.
- Bassir Nia, A., Medrano, B., Perkel, C., Galynker, I. and Hurd, Y.L. (2016) Psychiatric Comorbidity Associated with Synthetic Cannabinoid Use Compared to Cannabis. Journal of Psychopharmacology, 30, 1321-1330. https://doi.org/10.1177/0269881116658990